These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8394710)
1. Characterization of in vivo phosphorylation of activin type II receptor. Ichijo H; Yamashita H; ten Dijke P; Eto Y; Heldin CH; Miyazono K Biochem Biophys Res Commun; 1993 Aug; 194(3):1508-14. PubMed ID: 8394710 [TBL] [Abstract][Full Text] [Related]
2. Characterization of type II activin receptors. Binding, processing, and phosphorylation. Mathews LS; Vale WW J Biol Chem; 1993 Sep; 268(25):19013-8. PubMed ID: 8395525 [TBL] [Abstract][Full Text] [Related]
3. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Attisano L; Cárcamo J; Ventura F; Weis FM; Massagué J; Wrana JL Cell; 1993 Nov; 75(4):671-80. PubMed ID: 8242742 [TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of activin receptor from mouse embryonal carcinoma cells. Identification of its serine/threonine/tyrosine protein kinase activity. Nakamura T; Sugino K; Kurosawa N; Sawai M; Takio K; Eto Y; Iwashita S; Muramatsu M; Titani K; Sugino H J Biol Chem; 1992 Sep; 267(26):18924-8. PubMed ID: 1326537 [TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and binding properties of the human type II activin receptor. Donaldson CJ; Mathews LS; Vale WW Biochem Biophys Res Commun; 1992 Apr; 184(1):310-6. PubMed ID: 1314589 [TBL] [Abstract][Full Text] [Related]
6. Two distinct signaling pathways activated by activin A in glucose-responsive pancreatic beta-cell lines. Shibata H; Kanzaki M; Takeuchi T; Miyazaki J; Kojima I J Mol Endocrinol; 1996 Jun; 16(3):249-58. PubMed ID: 8782083 [TBL] [Abstract][Full Text] [Related]
7. Active complex formation of type I and type II activin and TGF beta receptors in vivo as studied by overexpression in zebrafish embryos. de Vries CJ; de Boer J; Joore J; Strähle U; van Achterberg TA; Huylebroeck D; Verschueren K; Miyazono K; van den Eijnden-van Raaij AJ; Zivkovic D Mech Dev; 1996 Feb; 54(2):225-36. PubMed ID: 8652415 [TBL] [Abstract][Full Text] [Related]
8. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Attisano L; Wrana JL; Cheifetz S; Massagué J Cell; 1992 Jan; 68(1):97-108. PubMed ID: 1310075 [TBL] [Abstract][Full Text] [Related]
9. Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis. Verschueren K; Dewulf N; Goumans MJ; Lonnoy O; Feijen A; Grimsby S; Vandi Spiegle K; ten Dijke P; Morén A; Vanscheeuwijck P; Heldin CH; Miyazono K; Mummery C; Van Den Eijnden-Van Raaij J; Huylebroeck D Mech Dev; 1995 Jul; 52(1):109-23. PubMed ID: 7577669 [TBL] [Abstract][Full Text] [Related]
10. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. Yamashita H; ten Dijke P; Huylebroeck D; Sampath TK; Andries M; Smith JC; Heldin CH; Miyazono K J Cell Biol; 1995 Jul; 130(1):217-26. PubMed ID: 7790373 [TBL] [Abstract][Full Text] [Related]
11. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Mathews LS; Vale WW Cell; 1991 Jun; 65(6):973-82. PubMed ID: 1646080 [TBL] [Abstract][Full Text] [Related]
12. A carboxyl-terminal truncated version of the activin receptor mediates activin signals in early Xenopus embryos. Nishimatsu S; Iwao M; Nagai T; Oda S; Suzuki A; Asashima M; Murakami K; Ueno N FEBS Lett; 1992 Nov; 312(2-3):169-73. PubMed ID: 1330691 [TBL] [Abstract][Full Text] [Related]
13. Formation and activation by phosphorylation of activin receptor complexes. Willis SA; Zimmerman CM; Li LI; Mathews LS Mol Endocrinol; 1996 Apr; 10(4):367-79. PubMed ID: 8721982 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3. Takumi T; Moustakas A; Lin HY; Lodish HF Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622 [TBL] [Abstract][Full Text] [Related]
15. Identification of a binding site on the type II activin receptor for activin and inhibin. Gray PC; Greenwald J; Blount AL; Kunitake KS; Donaldson CJ; Choe S; Vale W J Biol Chem; 2000 Feb; 275(5):3206-12. PubMed ID: 10652306 [TBL] [Abstract][Full Text] [Related]
16. Activin and inhibin binding to the soluble extracellular domain of activin receptor II. Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513 [TBL] [Abstract][Full Text] [Related]
17. Activation of signalling by the activin receptor complex. Attisano L; Wrana JL; Montalvo E; Massagué J Mol Cell Biol; 1996 Mar; 16(3):1066-73. PubMed ID: 8622651 [TBL] [Abstract][Full Text] [Related]
18. Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cells. Piek E; Afrakhte M; Sampath K; van Zoelen EJ; Heldin CH; ten Dijke P J Cell Physiol; 1999 Aug; 180(2):141-9. PubMed ID: 10395283 [TBL] [Abstract][Full Text] [Related]
20. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors. De Winter JP; De Vries CJ; Van Achterberg TA; Ameerun RF; Feijen A; Sugino H; De Waele P; Huylebroeck D; Verschueren K; Van Den Eijden-Van Raaij AJ Exp Cell Res; 1996 May; 224(2):323-34. PubMed ID: 8612709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]